https://mitogen.dev5.oracastdev.com/faq/does-the-ana-or-anti-cytoplasmic-antibody-pattern-have-any-diagnostic-value/ 2021-03-03T00:11:54+00:00 https://mitogen.dev5.oracastdev.com/faq/is-it-useful-to-repeat-and-monitor-autoantibody-levels-in-the-follow-up-of-patients-with-systemic-rheumatic-disease/ 2021-03-03T00:12:26+00:00 https://mitogen.dev5.oracastdev.com/faq/is-the-ana-indirect-immunofluorescence-assay-test-always-positive-in-the-workup-of-systemic-rheumatic-disease/ 2021-03-03T00:12:48+00:00 https://mitogen.dev5.oracastdev.com/faq/in-the-presence-of-a-positive-hep-2-ifa-screening-test-is-it-always-necessary-to-search-for-antibody-specificity/ 2021-03-03T00:13:17+00:00 https://mitogen.dev5.oracastdev.com/faq/is-it-important-to-define-titres-for-hep-2-ifa/ 2021-03-03T00:13:50+00:00 https://mitogen.dev5.oracastdev.com/faq/what-is-the-difference-between-the-anti-cellular-antibody-test-and-the-anti-nuclear-antibody-test/ 2021-03-03T00:14:09+00:00 https://mitogen.dev5.oracastdev.com/faq/when-is-it-useful-to-repeat-the-hep-2-ifa-anti-cellular-antibody-test-ana-or-ena-test/ 2021-03-03T00:14:24+00:00 https://mitogen.dev5.oracastdev.com/faq/for-cell-based-immunoassays-cba-such-as-anti-mog-myelin-oligodendrocyte-glycoprotein-are-results-indicating-a-change-a-positive-from-medium-to-high-clinically-significant/ 2025-07-22T19:14:43+00:00 https://mitogen.dev5.oracastdev.com/faq/what-does-the-designation-research-use-only-ruo-and-laboratory-developed-test-ldt-mean/ 2025-07-22T19:15:08+00:00 https://mitogen.dev5.oracastdev.com/faq/mypatient-is-receiving-ivig-intravenous-immunoglobulin-treatment-does-this-affectthe-results-of-the-autoantibody-and-related-serology-test-results/ 2025-07-22T19:17:19+00:00 https://mitogen.dev5.oracastdev.com/faq/does-the-ana-or-anti-cytoplasmic-antibody-pattern-have-any-diagnostic-value/ 2025-07-22T19:17:38+00:00 https://mitogen.dev5.oracastdev.com/faq/is-it-useful-to-repeat-and-monitor-autoantibody-levels-in-the-follow-up-of-patients-with-systemic-rheumatic-disease/ 2025-07-22T19:17:53+00:00 https://mitogen.dev5.oracastdev.com/faq/is-the-ana-indirect-immunofluorescence-assay-test-always-positive-in-the-workup-of-systemic-rheumatic-disease/ 2025-07-22T19:18:22+00:00 https://mitogen.dev5.oracastdev.com/faq/in-the-presence-of-a-positive-hep-2-ifa-screening-test-is-it-always-necessary-to-search-for-antibody-specificity/ 2025-07-22T19:18:47+00:00 https://mitogen.dev5.oracastdev.com/faq/is-it-important-to-define-titres-for-hep-2-ifa/ 2025-07-22T19:21:49+00:00 https://mitogen.dev5.oracastdev.com/faq/what-is-the-difference-between-the-anti-cellular-antibody-test-and-the-anti-nuclear-antibody-test/ 2025-07-22T19:22:04+00:00 https://mitogen.dev5.oracastdev.com/faq/when-is-it-useful-to-repeat-the-hep-2-ifa-anti-cellular-antibody-test-ana-or-ena-test/ 2025-07-22T19:22:21+00:00